ScreenCell is a simple and innovative technology for isolating Circulating Tumor Cells and potentially any large cell from whole blood or potentially other biological fluids (ascites, urine, pleural and cerebrospinal fluids..)
ScreenCell is a size-based antibody-independent technology applicable to all solid tumors (including melanoma and non-epithelial tumors). ScreenCell also provides easy access to clusters.
Our technology enables a wide range of applications: phenotypical, genotypical, and functional characterization either with fixed or live cells thanks to specific ScreenCell buffers.
HIGHLIGHTS OF THE TECHNOLOGY APPLICATIONS
ScreenCell CYTO and MB Kits are CE-IVD.